News |  Contact |  Sitemap |  Disclaimer | 
news
About us  |   Services  |   Territories  |   Partners  |  
Ewopharma takes over responsibility for meningitis C vaccine
13.01.2014

Ewopharma AG is pleased to announce its cooperation with Nuron Biotech, an innovative US company focused on vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases. As from January 2014, Ewopharma is exclusively marketing Meningitec in Hungary. Meningitec is a meningitis C vaccine that contains inactivated extracts of Neisseria meningitidis group C bacteria, a type of bacteria that causes meningitis. The vaccine works by provoking the body's immune response to this bacteria, without causing the disease. The meningitis C vaccine is part of the childhood immunization schedule. This extension of the pediatric portfolio further strengthens Ewopharma’s strong position in this market segment.